Four researchers from Stony Brook University — Michael A. Frohman, professor and chair in the Department of Pharmacological Sciences; Stefan Judex, associate professor in the Department of Biomedical Engineering; Lorna Role, professor and chair in the Department of Neurobiology and Behavior; and David Talmage, professor in the Department of Pharmacological Sciences — are part of the new regional collaborative Einstein-Mount Sinai Diabetes Research Center (DRC), which received a prestigious $10.5 million, five-year grant from the National Institutes of Health.
The DRC, originally established at Albert Einstein College of Medicine at Yeshiva University and Montefiore Health System, is now partnering with the Icahn School of Medicine at Mount Sinai to form the new regional center. In addition to Stony Brook, researchers from Cornell University, Well Cornell Medical College, Hunter College, Winthrop-University Hospital and NYU Langone Medical Center are also involved in the DRC.
Jeffrey Pessin, the Judy R. and Alfred A. Rosenberg Professorial Chair in Diabetes Research at Einstein and principal investigator on the grant, will direct the new multi-institution center. “We wanted to keep the conversation going all year long,” said Pessin, who is also professor of medicine and of molecular pharmacology at Einstein. “Our outstanding diabetes-specific core facilities, coupled with a robust and highly interactive research base and strong interactions with Mount Sinai, positioned us to create a regional diabetes research center.”
According to Pessin, the grant will help the DRC expand ongoing diabetes and metabolic disease research projects, initiate new research studies and promote advances in research technologies. The collaborative nature of the center will ultimately help speed findings from bench to bedside.
The DRC will receive additional support from the New York Obesity Research Center, the Center for the Study of Diabetic Complications and the Montefiore Clinical Diabetes Center.